Signos
PrivateLast Round
VC Round
May 27, 2026
Total Funding Raised
$41M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Signos is a digital health company that provides an AI-driven weight management platform that integrates real-time continuous glucose monitoring data to offer personalized dietary and lifestyle recommendations.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Health IoT, D2C Brands, Subscription Commerce
Business Model
B2C
Customer Profile
Hardware + Subscription
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Signos Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Signos Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 27, 2026 | ||||
| Series B | Oct 24, 2023 | ||||
| Series A | Nov 10, 2021 | ||||
| Seed | Jan 1, 2021 | ||||
| Seed | Dec 1, 2020 |
Key People
Founding team and executive leadership
Signos Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GV | VC Round, Series B, Series A |
| Dexcom Ventures | Series B |
| Courtside Ventures | Seed, Series A |
| Samsung NEXT Ventures | Series B |
| Samsung Next TLV | Series B |
| Tau Ventures | Seed, Series A |
| Cheyenne Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 27, 2026
$20M raised with participation from GV and DexCom.
- Aug 20, 2025
Launched FDA-cleared Glucose Monitoring solution for metabolic health.
Signos Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Signos's valuation, stock price, and market status.